MMP9 and toxic multinodular goitre: Our results indicated that MMP-9 regulation could be used as a potential biomarker to differentiate PTC from MNG, with 70% diagnostic precision; thus, it is suggested that using this gene as a potential diagnostic biomarker for PTC could be more helpful.